Amyris announced JV partnership with ImmunityBio for next generation COVID-19 RNA vaccine
On Nov. 8, 2021, Amyris announced announced it had entered into a 50:50 joint venture arrangement with ImmunityBio to accelerate the commercialization of a leading next-generation COVID-19 vaccine.
Tags:
Source: Amyris
Credit:
